Skip to main content


4 result(s) for 'author#Emilio Martín-Mola' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. The purpose of this study was to investigate the association between HLA-DRB1 alleles with susceptibility to rheumatoid arthritis (RA) and production of antibodies against citrullinated proteins (ACPA) and rhe...

    Authors: Alejandro Balsa, Arancha Cabezón, Gisela Orozco, Tatiana Cobo, Eugenia Miranda-Carus, Miguel Ángel López-Nevot, José Luis Vicario, Emilio Martín-Mola, Javier Martín and Dora Pascual-Salcedo
    Citation: Arthritis Research & Therapy 2010 12:R62
  2. Circulating CD4 T cells expressing CXCR5, ICOS and/or PD-1 are counterparts of follicular helper T cells (Tfh). There are three subpopulations of circulating Tfh (cTfh): CXCR5 + CXCR3 + CCR6- (Tfh-Th1), CXCR5 ...

    Authors: Irene Arroyo-Villa, María-Belén Bautista-Caro, Alejandro Balsa, Pilar Aguado-Acín, María-Gema Bonilla-Hernán, Chamaida Plasencia, Alejandro Villalba, Laura Nuño, Amaya Puig-Kröger, Emilio Martín-Mola and María-Eugenia Miranda-Carús
    Citation: Arthritis Research & Therapy 2014 16:500
  3. Anti-TNF drugs have proven to be effective against spondyloarthritis (SpA), although 30% of patients fail to respond or experience adverse events leading to treatment discontinuation. In rheumatoid arthritis, ...

    Authors: Chamaida Plasencia, Dora Pascual-Salcedo, Sara García-Carazo, Leticia Lojo, Laura Nuño, Alejandro Villalba, Diana Peiteado, Florencia Arribas, Jesus Díez, Maria Teresa López-Casla, Emilio Martín-Mola and Alejandro Balsa
    Citation: Arthritis Research & Therapy 2013 15:R79
  4. The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis...

    Authors: Juan J Gomez-Reino and Loreto Carmona
    Citation: Arthritis Research & Therapy 2006 8:R29